In this single-center prospective study of women with breast cancer treated with anthracycline-based chemotherapy, we observed that early changes in cardiac biomarkers, including NT-proBNP, correlate with changes in LVEF over the course of 6 months. The gene discussed is NPPB; the disease is breast carcinoma.